New Sotalol IV data published in Cardiology Research

August 2020 – The publication describes the FDA’s regulatory path for approving new Sotalol IV dosing for a 1-day initiation or dose escalation. The data shows how a 1-hour Sotalol IV infusion can quickly reach therapeutic levels and thus, reduce hospital length of stay from 3 days down to 1 day.


Leave a Reply

Your email address will not be published. Required fields are marked *